Ledipasvir/sofosbuvir plus ribavirin as highly effective regimen for recombinant strain RF1-2K/1B patients within georgian national hepatitis C elimination program

This article has no abstract
Epistemonikos ID: 0b9bb89d0fdfdcfe50b372cb8f66e249ff81bbdc
First added on: Feb 08, 2025